Literature DB >> 32155399

Prognostic Factors in Advanced Ovarian Cancer - A Clinical Trial.

Alexandra Ligia Dinca, Rodica Daniela Bîrla, Valeriu Gabi Dinca, Cristian Marica, Eugenia Panaitescu, Silviu Constantinoiu.   

Abstract

Introduction: Ovarian cancer is one of most fatal gynecological condition. The number of patients diagnosed in advanced stages is very high, hence the recurrence rate is high, and the chance of survival at 5 years is less than 45%. Purpose: To evaluate correspondance between overall survival with clinical, paraclinical, tumor or treatment characteristics and to identify prognostic factors in patients with advanced ovarian cancer - stage III and IV FIGO. Material and Method: We performed a retrospective study in 65 patients with advanced ovarian cancer - stages III and IV FIGO operated during 2010-2018, with a follow-up period of at least one year. There were correlations with clinical and paraclinical charateristics, tumor or treatment characteristics and with overall survival.
Results: In the univariate statistical analysis of survival, a significant statistical association is obtained by the presence of pelvic pain at presentation (p_value = 0.033744), with the stage III (p_value = 0.007595, respectively p_value = 0.022090), with the type of citoreduction (p_value = 0.035) , with postoperative complications (p_value = 0.000685) within the pathological subtypes (p_value = 0.046266), with adjuvant treatment (p_value = 0.000083). Cox multivariate regression analysis showed that adjuvant chemotherapy (HR = 0.046, 95% CI = (0.008, 0.261), (p_value = 0.000492), suboptimal cytoreduction (HR = 0.346, 95% CI = (0.140, 0.853), (p_value) = 0.021219) and postoperative complications (HR = 53,751, 95% CI = (4,672, 618,365), (p_value = 0.001389) are independent prognostic factors. Conclusions: Absence of pelvic pain at diagnosis, FIGO IIIC stage, suboptimal cytoreduction, presence of postoperative complications, inadequate adjuvant treatment and pathological type of clear cell cancer have been shown to be prognostic factors for overall survival. In patients with advanced ovarian cancer, the type of optimal citoreduction and adjuvant treatment are independent protective factors for overall survival, and the presence of postoperative complications has been shown to be an independent risk factor. Celsius.

Entities:  

Keywords:  ovariancancer; prognosticfactors; surgicalcytoreduction

Mesh:

Year:  2020        PMID: 32155399     DOI: 10.21614/chirurgia.115.1.50

Source DB:  PubMed          Journal:  Chirurgia (Bucur)        ISSN: 1221-9118


  8 in total

1.  Identification of the key genes associated with chemotherapy sensitivity in ovarian cancer patients.

Authors:  Hui Zheng; Meiqin Zhang; Shuang Ma; Wenting Yang; Suhong Xie; Yanchun Wang; Yixuan Liu; Jinyan Kai; Qian Ma; Renquan Lu; Lin Guo
Journal:  Cancer Med       Date:  2020-05-22       Impact factor: 4.452

2.  Prognostic Significance of CA125 Dynamic Change for Progression Free Survival in Patients with Epithelial Ovarian Carcinoma.

Authors:  Zemin Li; Han Yin; Mulan Ren; Yang Shen
Journal:  Med Sci Monit       Date:  2020-09-10

3.  A Novel Clinical Nomogram for Predicting Cancer-Specific Survival in Adult Patients After Primary Surgery for Epithelial Ovarian Cancer: A Real-World Analysis Based on the Surveillance, Epidemiology, and End Results Database and External Validation in a Tertiary Center.

Authors:  Xianli Li; Haoya Xu; Limei Yan; Jian Gao; Liancheng Zhu
Journal:  Front Oncol       Date:  2021-04-20       Impact factor: 6.244

4.  Two novel prognostic models for ovarian cancer respectively based on ferroptosis and necroptosis.

Authors:  Yang Li; Xiaojin Gong; Tongxiu Hu; Yurong Chen
Journal:  BMC Cancer       Date:  2022-01-17       Impact factor: 4.430

5.  Ideal Lymph Node Number for Ovarian Malignancies.

Authors:  İbrahim Karadağ; Serdar Karakaya
Journal:  Cureus       Date:  2022-01-02

6.  Exosomal miR-543 Inhibits the Proliferation of Ovarian Cancer by Targeting IGF2.

Authors:  Shupei Zhang; Diling Pan; Shaoyu Zhang; Qiumei Wu; Lan Zhen; Shihuang Liu; Jingjing Chen; Rong Lin; Qiuhua Hong; Xiangqin Zheng; Huan Yi
Journal:  J Immunol Res       Date:  2022-03-29       Impact factor: 4.818

7.  High expression of CD8 in the tumor microenvironment is associated with PD-1 expression and patient survival in high-grade serous ovarian cancer.

Authors:  Fatma Ölmez; Süleyman Cemil Oğlak; Ömer Fatih Ölmez; Özgür Akbayır; Ercan Yılmaz; Sedat Akgöl; Merve Konal; Niyazi Alper Seyhan; Alp Koray Kinter
Journal:  Turk J Obstet Gynecol       Date:  2022-09-23

8.  Ultrasound-Targeted Microbubble Destruction-Mediated Inhibition of Livin Expression Accelerates Ovarian Cancer Cell Apoptosis.

Authors:  Xiaolin Xu; Shuqin Yu; Xiaoyuan Liu; Ying Feng
Journal:  Genet Res (Camb)       Date:  2021-12-09       Impact factor: 1.588

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.